(Q37217007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

O Martínez-Iglesias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

L Ruiz-Llorente

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

R Sánchez-Martínez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

L García

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

A Aranda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

395-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18628067%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-008-0221-x

10 January 2020

exact match

0 references

cites work

Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12094-008-0221-X

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

21 January 2018

1 reference

12 December 2020

The Sir2 family of protein deacetylases

1 reference

12 December 2020

Identification of novel isoform-selective inhibitors within class I histone deacetylases

1 reference

12 December 2020

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

1 reference

12 December 2020

n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells

1 reference

12 December 2020

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

12 December 2020

Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes

1 reference

12 December 2020

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A

1 reference

12 December 2020

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

1 reference

12 December 2020

Regulation of tissue-specific and extracellular matrix-related genes by a class I histone deacetylase

1 reference

12 December 2020

Histone deacetylase inhibitors: discovery and development as anticancer agents

1 reference

12 December 2020

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

1 reference

12 December 2020

Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3

1 reference

12 December 2020

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

1 reference

12 December 2020

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

1 reference

12 December 2020

Anticancer activities of histone deacetylase inhibitors

1 reference

12 December 2020

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

12 December 2020

Histone deacetylase inhibitors: insights into mechanisms of lethality

1 reference

12 December 2020

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

1 reference

12 December 2020

Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR

1 reference

12 December 2020

Translating the Histone Code

1 reference

12 December 2020

HDAC inhibitors: clinical update and mechanism-based potential.

1 reference

12 December 2020

Histone deacetylase inhibitors: overview and perspectives

1 reference

12 December 2020

Histone deacetylase inhibitors: molecular mechanisms of action

1 reference

12 December 2020

Histone deacetylases and cancer

1 reference

12 December 2020

Histone acetylation and transcriptional regulatory mechanisms

1 reference

12 December 2020

Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells

1 reference

12 December 2020

Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

1 reference

12 December 2020